Enhancing Postpartum Contraception

Slides:



Advertisements
Similar presentations
Dr KANUPRIYA CHATURVEDI Dr. S.K. CHATURVEDI
Advertisements

How Using Family Planning to Time and Space Pregnancies Reduces Mortality Adrienne Allison, December 12, 2012.
Guanzon, Guerrero, Guerzon, Guevarra, Guinto, Gutierrez,
{ Bedsider for Postpartum Contraception Counseling Jennifer Bromley, MD ACOG Junior Fellow Resident,Ob/Gyn Karen Gerancher, MD Principal Investigator ACOG.
Brenda Dawley M.D.. Why high –risk? Unplanned Unwanted Substance abuse Lack prenatal care Increased risk certain pregnancy complications.
Contraception/Pregnancies MTN 020. Why do we care? Participants must come off product during pregnancy and breastfeeding – Studies of dapivirine in pregnant.
Contraceptive Implants
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Maternal and Newborn Health Training Package Session 8:
Breastfeeding Week 1-7 August Public education presentation Presented by: add your name 1 Created by Inge Kleinhans, 2013 Public Relations Officer of JuPHASA.
Post Natal Care of the Mother Cate Price Medical Advisor Obstetrics Shared Care.
Jhpiego in partnership with Save the Children, Constella Futures, The Academy for Educational Development, The American College of Nurse-Midwives and IMA.
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
Birth Control: what works best for YOU? Slides adapted from Ruth Lesnewski MD; FMDRL.org Katy Kropf DO Heritage College of Osteopathic Medicine November.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Maternal and Newborn Health Training Package Session 3:
Baby Friendly Health Initiative (BFHI) Accreditation
Successful Exclusive Breastfeeding For the First Six Months
Baby-Friendly Hospital Initiative. Quality of Life Families save between $1200 & $1500 in formula alone in the first year Fewer missed days of work.
Lactational Amenorrhoea Method
Session I, Slide 11 Lactational Amenorrhea Method (LAM) Session I: Characteristics of LAM.
Lactational Amenorrhea Method (LAM): Workshop for Maternal, Newborn, and Child Health (MNCH) Service Providers* Field-Test Draft, December 2009 Welcome.
Safe Sex & Birth Control Options. Making the decision Difficult decision When is the time right? Are you ready? What steps should you take to protect.
The Post-Partum Visit Re-Design Jeanne A. Conry, MD, PhD Chair, ACOG District IX.
Lactational Amenorrhea Method (LAM) :
The Role of the Midwife in Public Health Julie Foster Senior Lecturer University of Cumbria.
Arch Neurol. 2009;66(8): Published online June 8, 2009 (doi: /archneurol ).
Postpartum Care. TOPICS Routine care of the postpartum woman Routine care of the postpartum woman Common Problems in the postpartum period Common Problems.
Imarisha Maisha Postpartum family planning for CHWs.
Advanced Slide Set, Slide #1 Copper-Bearing Intrauterine Devices (IUDs) Advanced Slide Set Copper T 380A.
CHAPTER 17: Breastfeeding and Maternal Mental and Physical Health.
Contraceptive Options for Women and Couples with HIV.
Session II, Slide # 1 Copper-Bearing Intrauterine Devices (IUDs) Copper T 380A Session II: Who Can and Cannot Use IUDs?
Lactational Amenorrhea Method and Infant Feeding Options.
Jhpiego in partnership with Save the Children, Constella Futures, The Academy for Educational Development, The American College of Nurse-Midwives and IMA.
 Breastfeeding Curriculum Megan Mariner MD LATCH NOW.
Lactational Amenorrhea Method (LAM) Update for Training Skills Course
Session II, Slide 1 Lactational Amenorrhea Method (LAM) Session II: Who Can and Cannot Use LAM.
CPQC-HI MOM (Helping Infants with Mother’s Own Milk) Antenatal Platform Presentation November 10, 2015 Jodi Palmieri BSN, IBCLC St. Vincent’s Medical Center.
Optional Session III, Slide #1 Family Planning Counseling Optional Session Session III.
Session II, Slide # 1 Copper-Bearing Intrauterine Devices (IUDs) Copper T 380A Session II: Who Can and Cannot Use IUDs?
WHO Medical Eligibility Criteria for Contraceptive Use AAFP Global Workshop September 2012 Sharon Phillips MD, MPH Medical Officer Department of Reproductive.
FP Options for Extended Postpartum Dr. Bernabe Marinduque 20 March 2014.
Postpartum IUD Insertion Training
Adesina OA*, Awolude O, Oladokun A, Roberts A, Adewole IF, Department of Obstetrics & Gynaecology, College of Medicine, University of Ibadan. *Corresponding.
Welcome! As you get settled, please do the following: – Go to – Access the CDC Medical Eligibility Criteria.
Adapted and reproduced with permission from Alberta Health Services
#WorldBreastFeedingWeek
Purpose and Process of WHO guideline development
An Introduction to the Postpartum Family Planning Compendium
Ally Roy, MD Instructor Marshall University School of Medicine
Prenatal group care within a small family medicine residency clinic
Adapted and reproduced with permission from Alberta Health Services
Contraception in the over 40’s
Pathfinder International 2016
Evidence based Family planning
Pre-service Education on FP and AYSRH
Postpartum Contraception
Pre-service Education on FP and AYSRH
Session II: Who Can and Cannot Use IUDs?
Lactation Ammenorrhoea Method (LAM)
Baby-Friendly USA 10 Steps.
Progestin-Only Pills (POPs)
Lactational Amenorrhea Method (LAM) Who Can and Cannot Use LAM
Lactational Amenorrhea Method (LAM) Characteristics of LAM
Special Issues of Women’s Health Care and Reproduction
Progesterone Vaginal Ring Session 2: Who Can and Cannot Use the PVR
Post Abortion Contraception
Progestin-Only Pills (POPs)
Perinatal Quality improvement initiatives saint Anthony hospital
Presentation transcript:

Enhancing Postpartum Contraception Bhavik Kumar, MD Jennifer Amico, MD Marji Gold, MD Family Medicine Education Consortium November 1st, 2013

Objectives By the end of the presentation, participants should be able to: Summarize the evidence about VTE (venous thromboembolism) risk and breastfeeding during the postpartum period Use the MEC to help decide safe contraceptive options for postpartum women Counsel women about contraception during the postpartum period

Why is this important? Women may not want to be pregnant soon after delivery Ovulation can occur within 4wks after delivery Women often resume sexual activity before 4wks Birth spacing may reduce subsequent preterm delivery and low birth weight Women have enhanced access to care postpartum Repro coercion Ovulation: often preceeds menses, avg 25-39d in 25% of women, shorter interval in non-bf women Birth spacing: interval of <6mo and 6-12mo assoc/ with increased risk of preterm birth In low resource settings: An interval of <2yrs, higher malnutrition in first child and 2nd child higher risk low birth weight, preterm and death Access to care: can vary by state, for some insurance coverage ends at 6wks, big issue in other states outside NE DeFranco EA et al. Am J Obstet Gynecol 2007; 197(3): 264 Speroff L et al. Contraception. 2008; 78(2):90- Jackson E, Glasier A. Obstet Gynecol. 2011;(117):657-628 Byrd JE. J Fam Pract. 1998(4):305-8

What’s happening at your institution? Counseling Provision Training Counseling: what are we telling women about options, risks for contraceptive and risks of pregnancy during PP period? When are we counseling (antenatal, postpartum inpt, outpt)? What are current provision practices? What is available at discharge (OCPs, implants, IUD)? How is MS and resident training w/ PP contraception? Any specific training experiences from group?

Breastfeeding Should be encouraged for all women Lactational amenorrhea method (LAM) Theoretical concern about hormonal contraception decreasing milk supply http://mymillsbaby.co.uk/2013/08/midwives-and-breastfeeding-sensitivity-training/ BF benefits: bonding, cancer protection for mom (ovarian and breast), free, immunity to newborn, nutrition, reduced allergies, incr intelligence LAM: unpredictable in some, women not exclusively bf or formula feeding Must be exclusively bf – no solids, no pumping q4 hour during day, q6hour at night some recommend no separation of mother-baby also, no nonbreast sucking for baby Lactation raises prolactin levels Suppresses hypothalamic-pituitary-ovarian axis <2% in first 6mo postpartum w/ perfect use Research in 70s-80s: showed decrease milk production (COCP>POP>none) Systematic review in 2010 which included research since then showed no evidence of adverse effects w/ progestin-only methods w/ infant health or w/ bf Kapp N, et al. Contraception. 2010;(82):17-37

Postpartum period and VTE Increase in coagulation factors and fibrinogen Postpartum VTE risk increased compared to nonpregnant, non-postpartum women of reproductive age who are not using hormonal contraception Risk factors increase risk of VTE Immediate Postpartum 22-84 fold increase 21d (3wks) Postpartum 5-7 fold increase 42d (6wks) Postpartum Baseline risk Using CHC 3-7 fold increase Risk factors: Age >35, Smoking, Obesity, Thrombophilia, surgery (C/S), PPHemmorhage Jackson E, etal. Obstet Gynecol. 2011117):691-703 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a3.htm#tab1

United States Medical Eligibility Criteria (US MEC) for Contraceptive Use, 2010 How to access MEC, what is MEC, screenshots at end of PP if link does not work

US MEC for Postpartum Non-breastfeeding Women COC/P/R POP DMPA Implant <21 days 4 1 21-42 days w/ VTE risk factors 3 w/o VTE risk factors 2 >42 days http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a3.htm#tab1 1= no restriction 2 = advantages of using method outweigh the theoretical or proven risks 3 = theoretical or proven risks usually outweigh the advantages of method 4 – unacceptable health risk http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a3.htm#tab1

US MEC for Postpartum Breastfeeding Women COC/P/R POP DMPA Implant <21 days 4 2 21-30 days w/ VTE risk factors 3* w/o VTE risk factors 3 30-42 days 1 >42 days *women w/ VTE risk factors might increase to 4 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a3.htm#tab1

IUD Use in Breastfeeding and Non-breastfeeding Women LNG-IUD Cu-IUD <10min post-placenta 2 1 ≥10min after placenta to <4wks ≥4wks Puerperal sepsis 4 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a3.htm#tab1 Includes post c/s Higher expulsion rates (slightly) but comparable continuation rates Other methods: male condoms (vaginal dryness w/ bf), diaphragm (needs refitting), sponge (can use once bleeding stops), abstinence Safe to use EC during this period based on current evidence Sterilization has no effect on VTE risk or BF but evidence shows many who desire do not get (access, cost, etc.) – BTL, Essure, Vasectomy 1= no restriction 2 = advantages of using method outweigh the theoretical or proven risks 3 = theoretical or proven risks usually outweigh the advantages of method 4 – unacceptable health risk http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a3.htm#tab1

Case discussion – small groups What factors are important to consider? How would you counsel in these scenarios? What would you ultimately do and why? Case 1: You are discharging a postpartum 36yo woman from the hospital. She had a NSVD 2d prior and has done well since and has been breastfeeding without any issues. She asks you for a prescription for her preferred method of contraception, COCPs. Case 2: During a continuity session, a resident precepts a 24yo prenatal patient who presents for her 32wk visit. She has had a normal pregnancy so far. Last visit, contraceptive options were discussed with her. She has chosen an intrauterine device (IUD) and asks if she can have it placed immediately after birth. Case 3: A patient you followed during her prenatal care presents postpartum with baby. You are happy to observe that she is breastfeeding well and plans to continue for at least 6mo. When the topic of contraception comes up, she plans to use LAM.

Take home points Risk of VTE is highest immediately postpartum Evidence shows most contraceptive methods do not affect breastfeeding The CDC MEC is easily accessible The MEC should be used to make evidence-based decisions about contraception http://www.learningradiology.com/graphics/takehomepoint.gif

Thank you! Questions?